Hermetica Superfood Encyclopedia
The Short Answer
Ganoderma applanatum contains phenolics (22.9 mg GAE/g dry weight), flavonoids (15.84 mg QE/g), terpenoids (0.351 mg/g), and saponins (22.19 µg/mg) that exert antioxidant activity via free radical scavenging and antimicrobial effects through membrane-disrupting steroid and terpenoid compounds. In vitro studies demonstrate DPPH radical scavenging with an IC50 of approximately 50 µg/mL and antimicrobial inhibition at 100 µg/mL against pathogens including Escherichia coli and Staphylococcus aureus, with a minimum inhibitory concentration (MIC) as low as 6.25 µg/L for isolated compounds G1 and G2.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordGanoderma applanatum benefits
Artist's Conk — botanical close-up
Health Benefits
**Antioxidant Protection**
Methanolic extracts scavenge free radicals with an IC50 of ~50 µg/mL in DPPH assays, attributed largely to 2-tert-butyl-4-(1,1,3,3-tetramethylbutyl)phenol and the high phenolic content of 22.9 mg GAE/g dry weight; reducing power increases concentration-dependently up to 100 µg/mL.
**Antimicrobial Activity**
Isolated compounds G1 and G2 inhibit Escherichia coli and Staphylococcus aureus at MIC values as low as 6.25 µg/L, likely through disruption of bacterial membrane integrity via steroid and terpenoid moieties identified by GC-MS.
**Anti-Inflammatory Potential**
Triterpenoids and phenolic compounds present in the fruiting body are structurally analogous to known anti-inflammatory agents; broader Ganoderma genus research implicates these compound classes in suppression of pro-inflammatory cytokine signaling, though specific pathway data for G. applanatum remain preliminary.
**Immunomodulatory Support**
Polysaccharides characteristic of the Ganoderma genus, alongside the phenolic and saponin fractions (22.19 µg/mg), are associated with modulation of immune cell activity; these effects are documented at the genus level and are provisionally attributed to G. applanatum based on shared phytochemical profiles.
**Cytotoxic Activity Against Abnormal Cells**
Early-stage cytotoxicity studies on extracts indicate selective activity against cancer cell lines in vitro, consistent with the genus-wide profile of ganoderic acid-related triterpenoids; no clinical translation has been established for G. applanatum specifically.
**Nutritional Mineral Contribution**
The fruiting body contains measurable levels of calcium, sodium, phosphorus, and manganese, supporting its proposed use as a functional food supplement with micronutrient value beyond its secondary metabolite content.
**Hemolytic Safety and Biocompatibility**
Extracts tested against human red blood cells yielded a negative hemolysis result, confirming cytomembrane compatibility and supporting the safety basis for further development as an oral supplement ingredient.
Origin & History
Natural habitat
Ganoderma applanatum is a bracket fungus distributed across temperate and tropical forests worldwide, colonizing dead or dying hardwood trees such as beech, oak, and elm across Europe, North America, Asia, and Africa. It thrives in moist, shaded woodland environments, growing as a perennial polypore that can persist for decades on the same host substrate. Unlike cultivated mushrooms, it is predominantly wild-harvested, though its cosmopolitan distribution makes it accessible across diverse geographic regions.
“Ganoderma applanatum has a longstanding presence in ethnomycological traditions across East Asia, where bracket fungi of the Ganoderma genus have been valued for millennia as symbols of longevity and spiritual wellbeing, referenced in Chinese Taoist literature as 'Lingzhi' relatives—though G. lucidum holds the primary cultural designation. In Eastern European and Siberian folk medicine, the Artist's Conk was reportedly prepared as a decoction or poultice for inflammatory and infectious complaints, reflecting its widespread geographic availability. The common name 'Artist's Conk' derives from the practice of engraving images on the pale underside of the fruiting body, which oxidizes to brown upon scratching, a tradition documented among Indigenous North American peoples and European folk artists. Formal pharmacognostic investigation of the species is relatively recent, with systematic phytochemical characterization emerging primarily in the 21st century.”Traditional Medicine
Scientific Research
The current evidence base for Ganoderma applanatum consists exclusively of in vitro phytochemical characterization and bioactivity screening studies, with no published human clinical trials or animal intervention studies specific to this species as of the available literature. GC-MS analysis has identified 17 compounds in methanolic extracts, eight of which were reported as novel to the species, providing a preliminary chemical fingerprint; quantitative phytochemical profiling has yielded reproducible concentration data for phenolics, flavonoids, terpenoids, and saponins. Antioxidant (DPPH IC50 ~50 µg/mL) and antimicrobial (MIC 6.25 µg/L for isolated G1/G2 compounds) outcomes are based on cell-free and microbial culture assays, which, while indicative, do not predict human pharmacokinetics or therapeutic efficacy. The overall evidence quality is low by clinical standards; extrapolation from Ganoderma lucidum research is frequently made in the broader literature but is methodologically inappropriate without species-specific clinical validation.
Preparation & Dosage
Traditional preparation
**Methanolic Extract (Research Grade)**
Used at 50–100 µg/mL in in vitro bioactivity assays; no human-equivalent dose established.
**Traditional Decoction**
Fruiting body sliced and simmered in water for 30–60 minutes; concentration and standardization unknown, historically consumed as a medicinal tea in Asian folk medicine.
**Dried Whole Fruiting Body Powder**
1–3 g/day of dried powder, though this is not validated for G
No standardized dose; general Ganoderma genus precedent suggests . applanatum specifically.
**Dual Extraction (Water + Alcohol)**
Recommended preparation method to capture both water-soluble polysaccharides and alcohol-soluble triterpenoids; ratio and dosing remain unstandardized for this species.
**Standardization**
No commercial standardization percentages (e.g., % polysaccharides or % triterpenoids) have been established for G. applanatum; contrast with G. lucidum products standardized to ≥30% polysaccharides.
**Timing**
No evidence-based timing recommendations exist; general adaptogenic mushroom practice suggests daily consistent use over weeks to months.
Nutritional Profile
Ganoderma applanatum fruiting bodies contain a complex matrix of primary and secondary metabolites. Secondary metabolites quantified in methanolic extracts include phenolics at 22.9 mg GAE/g dry weight, flavonoids at 15.84 mg QE/g, terpenoids at 0.351 mg/g, and saponins at 22.19 µg/mg. GC-MS-identified compounds include 1,2-benzenedicarboxylic acid diethyl ester (29.53% relative peak area), 1,4-benzenedicarboxylic acid bis(2-ethylhexyl) ester (23.9%), and 2-tert-butyl-4-(1,1,3,3-tetramethylbutyl)phenol, alongside isolates with molecular formulas C20H34O4 (MW 334 Da, tannin-related) and C21H28O2 (MW 360 Da, terpenoid). Mineral analysis confirms the presence of calcium, sodium, phosphorus, and manganese; precise concentrations per serving are not established in available literature. Bioavailability of lipophilic triterpenoids is expected to be enhanced by concurrent dietary fat intake and may be potentiated by saponin content, consistent with general polypore mushroom pharmacokinetics.
How It Works
Mechanism of Action
The antioxidant mechanism of Ganoderma applanatum centers on hydrogen atom transfer and single-electron donation by phenolic hydroxyl groups, with 2-tert-butyl-4-(1,1,3,3-tetramethylbutyl)phenol identified by GC-MS as a principal radical-scavenging agent at IC50 ~50 µg/mL; the high phenolic load (22.9 mg GAE/g) correlates directly with reducing power at 700 nm absorbance. Antimicrobial action is attributed to terpenoid and steroid constituents—including the GC-MS-identified compounds 1,2-benzenedicarboxylic acid diethyl ester (29.53% peak area) and 1,4-benzenedicarboxylic acid bis(2-ethylhexyl) ester (23.9% peak area)—which are proposed to intercalate into or perturb bacterial membrane lipid bilayers, compromising membrane integrity and leading to cell death at MIC 6.25 µg/L. At the genus level, Ganoderma polysaccharides modulate immune function through Toll-like receptor engagement and downstream NF-κB pathway regulation, while triterpenoids inhibit pro-inflammatory enzymes such as cyclooxygenase; species-specific molecular pathway confirmation for G. applanatum awaits dedicated mechanistic studies. Saponins (22.19 µg/mg) may contribute secondary membrane-permeabilizing effects and potentiate bioavailability of co-occurring lipophilic triterpenoids through surfactant-like activity.
Clinical Evidence
No clinical trials in human subjects have been conducted on Ganoderma applanatum extracts or isolated compounds. All outcome data derive from in vitro systems: DPPH radical scavenging assays, agar diffusion and broth microdilution antimicrobial tests, and RBC hemolysis compatibility testing. The absence of pharmacokinetic studies means that effective in vitro concentrations (50–100 µg/mL) cannot currently be mapped to achievable human plasma levels through oral supplementation. Confidence in clinical applicability is very low, and any health claims must be regarded as speculative pending controlled human studies.
Safety & Interactions
In vitro hemolysis testing of Ganoderma applanatum extracts against human red blood cells produced negative results, indicating absence of membrane-lytic toxicity at tested concentrations and supporting baseline biocompatibility. No adverse effects, drug interactions, or contraindications have been identified in species-specific research, though the extremely limited human exposure data mean that rare or dose-dependent toxicities cannot be excluded. As with other Ganoderma species, theoretical interactions with anticoagulant medications (e.g., warfarin) and immunosuppressants are plausible given the genus-level immunomodulatory activity, and concurrent use should be approached cautiously until interaction studies are available. Pregnant and lactating individuals should avoid supplemental use due to the complete absence of reproductive safety data; individuals with known mushroom allergies should exercise caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ganoderma applanatum (Pers.) Pat.Artist's ConkArtist's BracketBear BreadBoletus applanatus Pers.Elfenbeinporling (German)
Frequently Asked Questions
What is Ganoderma applanatum used for medicinally?
Ganoderma applanatum is investigated for antioxidant, antimicrobial, and anti-inflammatory properties based on its phenolic (22.9 mg GAE/g), flavonoid (15.84 mg QE/g), and terpenoid content. In vitro studies show DPPH radical scavenging at IC50 ~50 µg/mL and inhibition of E. coli and S. aureus at MIC 6.25 µg/L for isolated compounds G1 and G2. All evidence is currently preclinical; no human clinical trials have confirmed these effects.
Is Ganoderma applanatum the same as Ganoderma lucidum (Reishi)?
No, Ganoderma applanatum (Artist's Conk) and Ganoderma lucidum (Reishi) are distinct species within the same genus and share some overlapping bioactive compound classes such as polysaccharides and triterpenoids. However, their specific phytochemical profiles, potencies, and evidence bases differ substantially; G. lucidum has far more clinical research supporting its use. The two should not be used interchangeably in supplementation without species-specific validation.
What are the main bioactive compounds in Ganoderma applanatum?
GC-MS analysis of methanolic extracts identified 17 compounds, with 1,2-benzenedicarboxylic acid diethyl ester (29.53% peak area) and 1,4-benzenedicarboxylic acid bis(2-ethylhexyl) ester (23.9% peak area) as the most abundant. Additional key compounds include 2-tert-butyl-4-(1,1,3,3-tetramethylbutyl)phenol (antioxidant), a tannin-related compound (C20H34O4, MW 334 Da), and a terpenoid isolate (C21H28O2, MW 360 Da). Eight of the 17 identified compounds were reported as novel to this species.
What is the recommended dose of Ganoderma applanatum supplement?
No standardized supplemental dose has been established for Ganoderma applanatum, as all research to date uses in vitro concentrations (50–100 µg/mL) that cannot be directly converted to human oral doses without pharmacokinetic studies. Traditional preparations involve decoctions of the dried fruiting body, and general Ganoderma genus precedent suggests 1–3 g/day of dried powder, but this has not been validated for this species. Consumers should exercise caution and consult a healthcare provider before use.
Is Ganoderma applanatum safe to consume?
In vitro hemolysis testing showed no toxic effect on human red blood cells, and no adverse effects have been reported in the limited available research. However, species-specific human safety data are essentially absent, making comprehensive risk assessment impossible at this time. Individuals taking anticoagulants or immunosuppressants, as well as pregnant or breastfeeding individuals, should avoid use until more safety data are available.
How does Ganoderma applanatum compare to other medicinal mushrooms for antioxidant protection?
Ganoderma applanatum demonstrates strong free radical scavenging capacity with an IC50 of approximately 50 µg/mL in DPPH assays, supported by a high phenolic content of 22.9 mg GAE/g dry weight. While both Ganoderma applanatum and Ganoderma lucidum (Reishi) possess antioxidant properties, Ganoderma applanatum's specific phenolic profile and concentration-dependent reducing power make it a potent option for antioxidant support. Its antioxidant activity rivals other medicinal mushroom species commonly used in traditional medicine.
What are the antimicrobial benefits of Ganoderma applanatum and which pathogens does it target?
Ganoderma applanatum contains isolated bioactive compounds (including G1 and G2) that demonstrate antimicrobial activity against common pathogens such as Escherichia coli. The antimicrobial properties are attributed to its unique bioactive compound profile, making it potentially useful for supporting immune defense against bacterial infections. Research into its spectrum of activity continues to identify additional pathogenic targets.
How does the phenolic content in Ganoderma applanatum affect its supplement effectiveness?
Ganoderma applanatum's high phenolic content of 22.9 mg GAE/g dry weight is largely responsible for its potent antioxidant activity and free radical scavenging capacity. The phenolic compounds, particularly 2-tert-butyl-4-(1,1,3,3-tetramethylbutyl)phenol, contribute directly to the supplement's bioactivity and its concentration-dependent effects. This high phenolic density suggests that standardized extracts rich in these compounds may offer superior antioxidant benefits compared to whole mushroom powder.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ganoderma-applanatum-ganoderma-applanatum-pers-pat curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
